Kytopen

Kytopen

Biotechnology, 750 Main St, Cambridge, Massachusetts, 02139, United States, 11-50 Employees

kytopen.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is KYTOPEN

Kytopen is focused on the development and commercialization of groundbreaking genome engineering platforms for expediting the discovery, development, and manufacture of gene-modified cell...

Read More

map
  • 750 Main St, Cambridge, Massachusetts, 02139, United States Headquarters: 750 Main St, Cambridge, Massachusetts, 02139, United States
  • 2017 Date Founded: 2017
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 5063

checked-icon Does something look wrong? Fix it. | View contact records from KYTOPEN

Kytopen Org Chart and Mapping

Employees

Devin Reslow

Computational Biologist

Eduardo Latouche

Director of Technology Innovation

Serana Burns

Senior Associate, Automation & Electrical Engineer

David Barone

Vice President of Product Development

Renee Conn

Assistant Director of Human Resources

Zakia Kirby

Supply Chain/Commercial Intern

John Zhao

Associate Director Process Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Kytopen

Answer: Kytopen's headquarters are located at 750 Main St, Cambridge, Massachusetts, 02139, United States

Answer: Kytopen's phone number is 61********

Answer: Kytopen's official website is https://kytopen.com

Answer: Kytopen's revenue is $10 Million to $25 Million

Answer: Kytopen's SIC: 5063

Answer: Kytopen has 11-50 employees

Answer: Kytopen is in Biotechnology

Answer: Kytopen contact info: Phone number: 61******** Website: https://kytopen.com

Answer: Kytopen is focused on the development and commercialization of groundbreaking genome engineering platforms for expediting the discovery, development, and manufacture of gene-modified cell therapies. Developed at MIT, the Flowfect platform, harmonizing microfluidics and automation, revolutionizes the delivery of genome engineering materials to cells of therapeutic interest in an expeditious, scalable, and economically advantageous manner compared to current alternatives. In May 2023, Kytopen unveiled the Flowfect DiscoverTM, an automated high-throughput genome engineering platform, and disclosed strategic partnerships with industry-leading Contract Development and Manufacturing Organizations (CDMOs) and translational academic medical centers. By combining Flowfect DiscoverTM with the Flowfect TxTM large-scale delivery device in process development workflows, developers can now surmount manufacturing challenges during the discovery stage, fostering swifter and more cost-effective innovation.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access